Afriyie-Mensah JS,Domoyeri P,Antwi-Boasiako C,Aryee R,Dankwah GB,Ntiamoah M,Dzudzor B,KusiMensah Y,Hayfron-Benjamin CF .2024 .Relationship between fraction of exhaled nitric oxide and peripheral eosinophilia in asthma. , 56(1) : 2382377.
Alqarni AA,Aldhahir AM,Alghamdi SA,Alqahtani JS,Siraj RA,Alwafi H,AlGarni AA,Majrshi MS,Alshehri SM,Pang L SM .2023 .Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD. Front Med, 10 : 1275684.
Bacharier LB,Pavord ID,Maspero JF,Jackson DJ,Fiocchi AG,Mao X,Jacob-Nara JA,Deniz Y,Laws E,Mannent LP,Amin N,Akinlade B,Staudinger HW,Lederer DJ,Hardin M .2024 .Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma. J. Allergy. Clin. Immunol, 154(1) : 101-110.
Barnes PJ .2016 .Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J. Allergy. Clin. Immunol, 138(1) : 16-27.
Bayarri MA,Milara J,Estornut C,Cortijo J .2021 .Nitric oxide system and bronchial epithelium: more than a barrier. Front Physiol, 12 : 687381.
Benson VS,Hartl S,Barnes N,Galwey N,Van Dyke MK,Kwon N MK .2022 .Blood eosinophil counts in the general population and airways disease: A comprehensive review and meta-analysis. Eur. Respir. J., 59(1) : 2004590.
Castro M,Papi A,Porsbjerg C,Lugogo NL,Brightling CE,González-Barcala FJ,Bourdin A,Ostrovskyy M,Staevska M,Chou PC,Duca L,Pereira AM,Fogarty C,Nadama R,Zhang M,Rodrigues A,Soler X,Sacks HJ,Deniz Y,Rowe PJ,Jacob-Nara JA .2025 .Effect of dupilumab on exhaled nitric oxide, mucus plugs and functional respiratory imaging in patients with type 2 asthma (VESTIGE): A randomised, double-blind, placebo-controlled, phase 4 trial. Lancet Respir. Med, 13(3) : 208-220.
Choi JY .2025 .Non-pharmacologic Prevention of AECOPD. Tuberc. Respir. Dis. (Seoul), 88(3) : 419-430.
Christenson SA,Smith BM,Bafadhel M,Putcha N M .2022 .Chronic obstructive pulmonary disease. Lancet, 399(10342) : 2227-2242.
David B,Bafadhel M,Koenderman L,De Soyza A L .2021 .Eosinophilic inflammation in COPD: From an inflammatory marker to a treatable trait. Thorax, 76(2) : 188-195.
Dawson RE,Jenkins BJ,Saad MI .2021 .IL-6 family cytokines in respiratory health and disease. Cytokine, 143 : 155520.
Escamilla-Gil JM,Fernandez-Nieto M,Acevedo N M .2022 .Understanding the cellular sources of the fractional exhaled nitric oxide (FeNO) and its role as a biomarker of type 2 inflammation in asthma. Biomed. Res. Int., : 5753524.
Fan X,Zhao N,Yu Z,Yu H,Yin B,Zou L,Zhao Y,Qian X,Sai X,Qin C,Fu C,Hu C,Di T,Yang Y,Wu Y,Bian T Y .2021 .Clinical utility of central and peripheral airway nitric oxide in aging patients with stable and acute exacerbated chronic obstructive pulmonary disease. Int. J. Gen. Med, 14 : 571-580.
Fuschillo S,Paris D,Tramice A,Ambrosino P,Palomba L,Maniscalco M,Motta A .2022 .Metabolomic profiling of exhaled breath condensate and plasma/ serum in chronic obstructive pulmonary disease. Curr. Med, 29(14) : 2385-2398.
Gibson PG .2018 .Variability of blood eosinophils as a biomarker in asthma and COPD. , 23(1) : 12-13.
Golubic R,Mumbole H,Ismail MH,Choo A,Baker O,Atha K,Mei SCS,Raj A,Anand P,Aung NO,Kumar NS,Nahar T,Coleman RL,Tomlinson JW,Rahman N,Caleyachetty R,Adler A .2025 .Glucocorticoid treatment and new-onset hyperglycaemia and diabetes in people living with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Diabet Med, 42(3) : e15475.
Hu HS,Wang Z,Zhao LM,Liu XD .2022 .Nebulized corticosteroids versus systemic corticosteroids for patients with acute exacerbation of chronic obstructive pulmonary disease: A systematic review and metaanalysis comparing the benefits and harms reported by observational studies and randomized controlled trials. Front Pharmacol, 13 : 966637.
Keeratichananont W,Kaenmuang P,Geater SL,Denyuk R,Kanchanakanok C .2024 .Correlation of fractional exhaled nitric oxide (FeNO) and clinical outcomes in patients with chronic obstructive pulmonary disease: A prospective cohort study. Respir. Med, 229 : 107682.
Koarai A,Yamada M,Ichikawa T,Fujino N,Sugiura H N .2024 .Treatment with systemic corticosteroid versus placebo for exacerbations of COPD: A systematic review and meta-analysis. Respir. Investig., 62(3) : 503-511.
Kon SS,Canavan JL,Jones SE,Nolan CM,Clark AL,Dickson MJ,Haselden BM,Polkey MI,Man WD MI .2014 .Minimum clinically important difference for the COPD assessment test: A prospective analysis. Lancet Respir. Med, 2(3) : 195-203.
Lea S,Higham A,Beech A,Singh D A .2023 .How inhaled corticosteroids target inflammation in COPD. Eur. Respir. Rev., 32(170) : 230084.
Lee JH,Kang SY,Yu I,Park KE,Oh JY,Lee JH,Park SY,Kim MH,Jo EJ,Moon JY,Kim SH,Kim SH,Lee BJ,Song WJ .2024 .Cough response to high-dose inhaled corticosteroids in patients with chronic cough and fractional exhaled nitric oxide levels ≥ 25 ppb: A prospective study. Lung, 202(3) : 275-280.
Liu X,Zhang H,Wang Y,Lu Y,Gao Y,Lu Y,Zheng C,Yin D,Wang S,Huang K S .2020 .Fractional exhaled nitric oxide is associated with the severity of stable COPD. , 17(2) : 121-127.
Machado A,Barusso M,De Brandt J,Quadflieg K,Haesevoets S,Daenen M,Thomeer M,Ruttens D,Marques A,Burtin C .2023 .Impact of acute exacerbations of COPD on patients' health status beyond pulmonary function: A scoping review. Pulmonology, 29(6) : 518-534.
Maniscalco M,Candia C,Fuschillo S,Ambrosino P,Motta A .2024 .Exhaled breath condensate (EBC) in respiratory diseases: Recent advances and future perspectives in the age of omic sciences. J. Breath. Res., 18(4) : 1752.
Munuswamy R,De Brandt J,Burtin C,Derave W,Aumann J,Spruit MA,Michiels L MA .2021 .Monomeric CRP is elevated in patients with COPD Compared to NonCOPD Control Persons. J. Inflamm. Res., 14 : 4503-4507.
Polverino F and Sin DD .2024 .Type 2 airway inflammation in COPD. Eur. Respir. J., 63(5) : 2400150.
Rastoder E,Sivapalan P,Eklöf J,Saeed MI,Jordan AS,Meteran H,Tønnesen L,Biering-Sørensen T,Løkke A,Seersholm N,Lynghøj Nielsen T,Carlsen J,Janner J,Godtfredsen N,Bodtger U,Laursen CB,Hilberg O,Knop FK,Priemé H,Ingebrigtsen TS,Gottlieb V,Wilcke JT,Staehr Jensen JU .2021 .Systemic corticosteroids and the risk of venous thromboembolism in patients with severe COPD: A nationwide study of 30,473 outpatients. , 9(8) : 874.
Rupani H,Kent BD H .2022 .Using fractional exhaled nitric oxide measurement in clinical asthma management. Chest, 161(4) : 906-917.
Rutkowski S,Rutkowska A,Kiper P,Jastrzebski D,Racheniuk H,Turolla A,Szczegielniak J,Casaburi R .2020 .Virtual reality rehabilitation in patients with chronic obstructive pulmonary disease: A randomized controlled trial. Int. J. Chron. Obstruct. Pulmon. Dis., 15 : 117-124.
Su KC,Ko HK,Hsiao YH,Chou KT,Chen YW,Yu WK,Pan SW,Feng JY,Perng DW .2022 .Fractional exhaled nitric oxide guided-therapy in chronic obstructive pulmonary disease: A stratified, randomized, controlled trial. Arch, 58(8) : 601-610.
Suissa S,Dell'Aniello S and Ernst P .2018 .Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: A population-based cohort study. Lancet Respir. Med, 6(11) : 855-862.
Yamaji Y,Oishi K,Hamada K,Ohteru Y,Chikumoto A,Murakawa K,Matsuda K,Suetake R,Murata Y,Ito K,Asami-Noyama M,Edakuni N,Hirano T,Matsunaga K .2020 .Detection of type2 biomarkers for response in COPD. J. Breath Res., 14(2) : 026007.
Zeng G,Xu J,Zeng H,Wang C,Chen L,Yu H (2024). L . .Differential clinical significance of feno(200) and cano in asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO). J. Asthma. Allergy., 17 : 1151-1161.